| [1] | Yap TL, Xu T, Chen YL, Malet H, Egloff MP, Canard B, Vasudevan SG, Lescar J: Crystal structure of the dengue virus RNA-dependent RNA polymerase catalytic domain at 1.85-angstrom resolution. J Virol 2007, 81: 4753-4765. |
| |
| [2] | Tsai TF. Flaviviruses (yellow fever virus, Dengue, Dengue hemorrhagic fever, Japanese encephalitis, St. Louis encephalitis, tick-borne encephalitis). In: Principles and practice of Infectious Diseases. Eds. Mandell GL, Bennett JE and Dolin R. 5th Ed. Vol 2. Churchill-Livingstone, New York 2000; 1714-1736. |
| |
| [3] | Monath TP, Tsai TF. Flaviviruses. In: Richman DD, Whitley RJ, Hayden FG, eds. Clinical Virology. New York: Churchill-Livingstone; 1977: 1133. |
| |
| [4] | Natasha Evelyn Anne Murray, Mikkel B Quam, Annelies Wilder-Smith. Epidemiology of dengue: past, present and future prospects. Clinical Epidemiology 2013; 5: 299-309. |
| |
| [5] | WHO TDR Global Alert and Repsonse Dengue/Dengue Haemorrhagic Fever [webpage on the Internet]. Geneva: World Health Organization (WHO); 2013 [cited August 3, 2013]. Available from: http://www.who. int/csr/disease/dengue/en/index.html. |
| |
| [6] | http://www.denguematters.info/content/issue-12-dengue-updates-february-2013#sthash.V9Xlt5C4.dpuf. |
| |
| [7] | Dengue, countries or areas at risk, 2011. Geneva: World Health Organization (WHO); 2012. Available from: http://gamapserver.who.int/mapLibrary/ Files/Maps/Global_DengueTransmission_ITHRiskMap.png. Accessed July 30, 2014. |
| |
| [8] | Gubler DJ. The global emergence/resurgence of arboviral diseases as public health problems. Arch Med Res. 2002; 33(4): 330-342. 20,000 deaths. |
| |
| [9] | Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, et al. 2013The global distribution and burden of dengue. Nature 2013; 496: 504-507. |
| |
| [10] | Anita Chakravarti, Rohit Arora, Christine Luxemburge. Fifty years of dengue in India. Transactions of the Royal Society of Tropical Medicine and HygieneVolume 106, Issue 5, May 2012, Pages 273-282. |
| |
| [11] | Shu PY, Huang JH. Current advances in dengue diagnosis. Clinical and Diagnostic Laboratory Immunology, 2004, 11(4): 642-650. |
| |
| [12] | Santiago GA, Vergne E, Quiles Y, Cosme J, Vazquez J, et al. (2013) Analytical and Clinical Performance of the CDC Real Time RT-PCR Assay for Detection and Typing of Dengue Virus. PLoS Negl Trop Dis 7(7): e2311. |
| |
| [13] | Endy TP, Anderson KB, Nisalak A, et al. Determinants of in apparent and symptomatic dengue infection in a prospective study of primary school children in Kamphaeng Phet, Thailand. PLoS Negl Trop Dis. 2011;5(3):e975. |
| |
| [14] | Dengue guidelines for diagnosis, treatment, prevention and control. A joint publication of the World Health Organization (WHO) and the Special Programme for Research and Training in Tropical Diseases (TDR). 2009 WHO Library Cataloguing-in-Publication Data. |
| |
| [15] | Immunization, Vaccines and Biologicals. Available at http://www.who.int/immunization/research/development/dengue_vaccines/en/. |
| |
| [16] | WHO. Global strategic framework for integrated vector management. Geneva, World Health Organization, 2004 (Document WHO/CDS/CPE/2004.10, available at: http://whqlibdoc.who.int/hq/2004/WHO_CDS_CPE_PVC_2004_10.pdf; accessed August 2014). |
| |